BIO CELL products
BIO CELL products are the mesenchymal stem cell (MSC)-based products that are manufactured under the sterile condition following the international guidelines (International Society for Cellular Therapy: ISCT)
BIO CELL products are tested and qualified by the safety assays including the toxicity testing, bacterial contamination testing, and fungal contamination testing.
BIO CELL products are produced from the fresh and naïve MSCs to maximize the product quality and treatment efficacy.
Eyes
-
Corneal ulcer
Joint
-
Rheumatoid arthritis (RA)
-
Osteoarthritis (OA)
-
Joint trauma
Nervous system
-
Paralysis
-
Spinal trauma
-
Intervertebral disc disease (IVDD)
-
Nerve trauma
" Stem cells are the essential components of the healthy organs and body "
Product series
BIO CELL Regen-cMSCs for eyes
Treatment of corneal ulcer (moderate to severe)
Process & product control
-
MSC characterization based on the International Society for Cellular Therapy (ISCT) (passed)
-
Acute systemic toxicity test in mouse model (passed)
Batch control
-
Bacterial & fungal contamination test (passed)
cMSCs
-
Naive MSCs
-
Sterile, non-preservatives
BIO CELL Regen-cMSCs for joints (Intraarticular injection)
Treatment of rheumatoid arthritis (RA), osteoarthritis (OA) and joint trauma
cMSCs
-
Naive MSCs
-
Sterile, non-preservatives
Process & product control
-
MSC characterization based on the International Society for Cellular Therapy (ISCT) (passed)
-
Acute systemic toxicity test in mouse model (passed)
Batch control
-
Bacterial & fungal contamination test (passed)
BIO CELL Engineered-chondrocyte progenitors
with Regen-cMSCs for joints (Intraarticular injection)
Treatment of osteoarthritis (OA)
cMSCs-derived chondrocyte progenitors
cMSCs
-
Naive MSCs
-
Sterile, non-preservatives
Process & product control
-
MSC characterization based on the International Society for Cellular Therapy (ISCT) (passed)
-
Acute systemic toxicity test in mouse model (passed)
Batch control
-
Bacterial & fungal contamination test (passed)
BIO CELL Engineered-neuroprogenitors
with Regen-cMSCs for intrathecal or perineural injection
Treatment of paralysis, spinal trauma, intervertebral disc disease (IVDD) and nerve trauma
cMSCs-derived neuroprogenitors
cMSCs
-
Naive MSCs
-
Sterile, non-preservatives
Process & product control
-
MSC characterization based on the International Society for Cellular Therapy (ISCT) (passed)
-
Acute systemic toxicity test in mouse model (passed)
Batch control
-
Bacterial & fungal contamination test (passed)
*Treatment outcome relies on the disease conditions and causes.